TMCnet News
Global In-Vitro Diagnostic (IVD) Market Size, Trends & Forecasts Report 2017-2021 Featuring Abbott Laboratories, Danaher, Roche & Siemens - Research and MarketsThe "Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021)" report has been added to Research and Markets' offering. Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021), provides analysis of the global In-Vitro Diagnostic, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by products, by technology and by region. The report also provides the analysis of the global in-vitro diagnostic market of the US, Europe, Asia and ROW regions. The global in-vitro diagnostics (IVD) market is expected to increase at high growth rates during the forecasted period (2017-2021). The global in-vitro diagnostics is supported by various growth drivers, such as, increasing disposale income, increasing obese population, swelling diabetic population, rising healthcare expenditure, etc. Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global in-vitro diagnostic has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Roche Holding, Danaher Corporation (News - Alert), Abbott Laboratories and Siemens Group are some of the key players operating in the global in-vitro diagnostic market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Global Market Analysis 4. Regional Market Analysis 5. Market Dynamics 6. Competitive Landscape 7. Company Profiles For more information about this report visit https://www.researchandmarkets.com/research/4txjv8/global_invitro View source version on businesswire.com: http://www.businesswire.com/news/home/20171204005884/en/ |
